Interdigitating Dendritic Cell Sarcoma — Trials

Interdigitating Dendritic Cell Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

38 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 25
Recruiting: 12
Ph III recruiting: 1
Growth YoY: —
Industry share: 8%
Top sponsor: The First Affiliated Hospital of Xiamen University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05950802	Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta(ODIN)	recruiting	Phase 1	40	University Health Network, TorontoOTHER	1	Dec 8, 2025	clinicaltrials
NCT06712810	Q702 for the Treatment of Patients With Hematologic Malignancies	recruiting	Phase 1	46	Mayo ClinicOTHER	1	Oct 10, 2025	clinicaltrials